人工智能驱动的抗菌发现:采矿和生成
Paulina Szymczak1, Wojciech Zarzecki2,3, Jiejing Wang4
1Institute of AI for Health, Helmholtz Zentrum Munich, Neuherberg 85764, Germany.
Accounts of chemical research
|June 3, 2025
概括
人工智能 (AI) 加快了对抗微生物 (AMP) 的发现,以对抗抗微生物耐药性 (AMR). 采矿和生成等人工智能方法识别和设计强效,少毒的AMP,用于下一代疗法.
科学领域:
- 生物医学研究生物医学研究
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 抗菌素耐药性 (AMR) 是日益严重的全球卫生危机,需要超越传统抗生素的新型治疗策略.
- 抗微生物 (AMP) 由于细菌选择性和耐药性发展缓慢,显示出有前途,但设计复杂.
- 庞大的序空间和低毒性的平衡效果在AMP开发中提出了重大挑战.
研究的目的:
- 探索人工智能 (AI) 在加速抗微生物 (AMP) 发现中的应用.
- 详细介绍人工智能驱动的战略,用于识别和设计新的AMP来打击抗菌素耐药性 (AMR).
- 讨论AI在克服AMP设计和开发中的挑战方面的潜力.
主要方法:
- AMP挖矿:利用人工智能扫描生物序列,寻找潜在的AMP候选人.
- 歧视性模型:使用人工智能来预测已识别的的活性和毒性.
- AMP生成:利用生成性AI模型创建具有优化的治疗性质的新序列.
主要成果:
- 人工智能驱动的AMP挖矿成功识别并通过实验验证了有前途的AMP候选人.
- 生成型人工智能模型显示了设计合成的潜力,其有效性提高,毒性降低.
- 人工智能方法促进了药物发现的序空间的高效导航.
结论:
- 人工智能与AMP发现的整合提供了一种强大的方法来对抗AMR.
- 人工智能可以加快新型,有效和安全的抗微生物的识别和设计.
- 在生物医学研究中持续整合人工智能对于开发下一代抗菌疗法至关重要.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.1K
13:49Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
Published on: December 6, 2017
11.5K
相关概念视频
Antimicrobial Proteins
6.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
6.5K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
